TY - JOUR
T1 - Enteroendocrine Connections in Congenital Isolated GH Deficiency Due to a GHRH Receptor Gene Mutation
AU - Oliveira-Santos, Alecia A.
AU - Salvatori, Roberto
AU - Nogueira, Monica C.
AU - Bueno, Ana C.
AU - Barros-Oliveira, Cynthia S.
AU - Leal, Ângela C.G.B.
AU - Marinho, Cindi G.
AU - Damascena, Nayra P.
AU - Oliveira, Djane A.
AU - Melo, Manuela A.
AU - Oliveira, Carla R.P.
AU - Da Costa, Flavia O.
AU - Dos Santos, Jinssica S.S.
AU - Santos, Paula F.C.
AU - Campos, Viviane C.
AU - Santos, Elenilde G.
AU - Melo, Enaldo V.
AU - Barbosa, Meirielly L.A.
AU - Rocha, Ivina E.S.
AU - De Castro, Margaret
AU - Aguiar-Oliveira, Manuel H.
N1 - Funding Information:
Financial Support: This study was supported in part by Sao Paulo Research Foundation Grant 2014/03989-6 (to M.d.C.).
Publisher Copyright:
© 2019 Endocrine Society.
PY - 2019/3/21
Y1 - 2019/3/21
N2 - GH and IGF-1 are crucial for attainment of normal body size and regulation of food intake, nutrient storage, and insulin sensitivity. Enteroendocrine connections exist between the GH-IGF-1 axis and insulin, ghrelin, and glucagon-like peptide 1 (GLP-1). The status of these connections in GH deficiency (GHD) is unknown. Objective: To study the enteroendocrine connections before and after a standard meal test in a homogeneous population of adults with congenital untreated isolated GHD (IGHD) due to a mutation in the GHRH receptor gene. Design: In a cross-sectional study of 20 individuals with IGHD and 20 control subjects, we measured glucose, insulin, ghrelin, and GLP-1 before and 30, 60, 120, and 180 minutes after a standardized test meal. Homeostasis model assessment index of insulin resistance (HOMA-IR) and homeostasis model assessment (HOMA)-b were calculated. Participants scored feelings of hunger, fullness, and prospective food consumption on a visual analog scale. Main Outcome Measures: Area under the curve (AUC) values of glucose, insulin, ghrelin, GLP-1, hunger, fullness, and prospective food consumption. Results: Fasting HOMA-IR and HOMA-b were lower in individuals with IGHD than in control subjects (P 5 0.002 and P 5 0.023, respectively). AUC was higher for hunger (P , 0.0001), glucose (P 5 0.0157), ghrelin (P , 0.0001), and GLP-1 (P , 0.0001) and smaller for fullness (P , 0.0001) in individuals with IGHD compared with control subjects. There was no difference in AUC for prospective food consumption or insulin.
AB - GH and IGF-1 are crucial for attainment of normal body size and regulation of food intake, nutrient storage, and insulin sensitivity. Enteroendocrine connections exist between the GH-IGF-1 axis and insulin, ghrelin, and glucagon-like peptide 1 (GLP-1). The status of these connections in GH deficiency (GHD) is unknown. Objective: To study the enteroendocrine connections before and after a standard meal test in a homogeneous population of adults with congenital untreated isolated GHD (IGHD) due to a mutation in the GHRH receptor gene. Design: In a cross-sectional study of 20 individuals with IGHD and 20 control subjects, we measured glucose, insulin, ghrelin, and GLP-1 before and 30, 60, 120, and 180 minutes after a standardized test meal. Homeostasis model assessment index of insulin resistance (HOMA-IR) and homeostasis model assessment (HOMA)-b were calculated. Participants scored feelings of hunger, fullness, and prospective food consumption on a visual analog scale. Main Outcome Measures: Area under the curve (AUC) values of glucose, insulin, ghrelin, GLP-1, hunger, fullness, and prospective food consumption. Results: Fasting HOMA-IR and HOMA-b were lower in individuals with IGHD than in control subjects (P 5 0.002 and P 5 0.023, respectively). AUC was higher for hunger (P , 0.0001), glucose (P 5 0.0157), ghrelin (P , 0.0001), and GLP-1 (P , 0.0001) and smaller for fullness (P , 0.0001) in individuals with IGHD compared with control subjects. There was no difference in AUC for prospective food consumption or insulin.
UR - http://www.scopus.com/inward/record.url?scp=85066870407&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066870407&partnerID=8YFLogxK
U2 - 10.1210/jc.2019-00094
DO - 10.1210/jc.2019-00094
M3 - Article
C2 - 30860584
AN - SCOPUS:85066870407
SN - 0021-972X
VL - 104
SP - 2777
EP - 2784
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 7
M1 - jcem_201900094
ER -